BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 11729018)

  • 1. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Ding YS; Sedler M; Logan J; Franceschi D; Gatley J; Hitzemann R; Gifford A; Wong C; Pappas N
    Am J Psychiatry; 2001 Dec; 158(12):2015-21. PubMed ID: 11729018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Angrist B; Gatley SJ; Logan J; Ding YS; Pappas N
    Am J Psychiatry; 1999 Jan; 156(1):19-26. PubMed ID: 9892293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.
    London ED; Simon SL; Berman SM; Mandelkern MA; Lichtman AM; Bramen J; Shinn AK; Miotto K; Learn J; Dong Y; Matochik JA; Kurian V; Newton T; Woods R; Rawson R; Ling W
    Arch Gen Psychiatry; 2004 Jan; 61(1):73-84. PubMed ID: 14706946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
    Volkow ND; Fowler JS; Wang GJ; Hitzemann R; Logan J; Schlyer DJ; Dewey SL; Wolf AP
    Synapse; 1993 Jun; 14(2):169-77. PubMed ID: 8101394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
    Sekine Y; Minabe Y; Ouchi Y; Takei N; Iyo M; Nakamura K; Suzuki K; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Mori N
    Am J Psychiatry; 2003 Sep; 160(9):1699-701. PubMed ID: 12944350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Wong C; Logan J
    Am J Psychiatry; 2001 Mar; 158(3):383-9. PubMed ID: 11229978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
    Iyo M; Nishio M; Itoh T; Fukuda H; Suzuki K; Yamasaki T; Fukui S; Tateno Y
    Psychiatry Res; 1993 Dec; 50(4):217-31. PubMed ID: 8177922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
    Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
    Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.
    Wang GJ; Volkow ND; Chang L; Miller E; Sedler M; Hitzemann R; Zhu W; Logan J; Ma Y; Fowler JS
    Am J Psychiatry; 2004 Feb; 161(2):242-8. PubMed ID: 14754772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased dopamine activity predicts relapse in methamphetamine abusers.
    Wang GJ; Smith L; Volkow ND; Telang F; Logan J; Tomasi D; Wong CT; Hoffman W; Jayne M; Alia-Klein N; Thanos P; Fowler JS
    Mol Psychiatry; 2012 Sep; 17(9):918-25. PubMed ID: 21747399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.
    Lee B; London ED; Poldrack RA; Farahi J; Nacca A; Monterosso JR; Mumford JA; Bokarius AV; Dahlbom M; Mukherjee J; Bilder RM; Brody AL; Mandelkern MA
    J Neurosci; 2009 Nov; 29(47):14734-40. PubMed ID: 19940168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
    Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
    Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers.
    Wiers CE; Shumay E; Cabrera E; Shokri-Kojori E; Gladwin TE; Skarda E; Cunningham SI; Kim SW; Wong TC; Tomasi D; Wang GJ; Volkow ND
    Transl Psychiatry; 2016 Mar; 6(3):e752. PubMed ID: 26954979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
    Okita K; Ghahremani DG; Payer DE; Robertson CL; Mandelkern MA; London ED
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26657175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex.
    Volkow ND; Fowler JS
    Cereb Cortex; 2000 Mar; 10(3):318-25. PubMed ID: 10731226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors.
    Volkow ND; Wang GJ; Begleiter H; Porjesz B; Fowler JS; Telang F; Wong C; Ma Y; Logan J; Goldstein R; Alexoff D; Thanos PK
    Arch Gen Psychiatry; 2006 Sep; 63(9):999-1008. PubMed ID: 16953002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.
    Sekine Y; Ouchi Y; Takei N; Yoshikawa E; Nakamura K; Futatsubashi M; Okada H; Minabe Y; Suzuki K; Iwata Y; Tsuchiya KJ; Tsukada H; Iyo M; Mori N
    Arch Gen Psychiatry; 2006 Jan; 63(1):90-100. PubMed ID: 16389202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
    Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
    Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
    Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.